You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Venom‐derived inhibitors of NaV1.7 channels
|
|---|---|
| Published in |
British Journal of Pharmacology, March 2015
|
| DOI | 10.1111/bph.13081 |
| Pubmed ID | |
| Authors |
Julie K Klint, Jennifer J Smith, Irina Vetter, Darshani B Rupasinghe, Sing Yan Er, Sebastian Senff, Volker Herzig, Mehdi Mobli, Richard J Lewis, Frank Bosmans, Glenn F King |
| Abstract |
Chronic pain is a serious worldwide health issue, with current analgesics having limited efficacy and dose-limiting side effects. Humans with loss-of-function mutations in the voltage-gated sodium channel NaV 1.7 (hNaV 1.7) are indifferent to pain, making hNaV 1.7 a promising target for analgesic development. Since spider venoms are replete with NaV channel modulators, we examined their potential as a source of hNaV 1.7 inhibitors. |
X Demographics
The data shown below were collected from the profiles of 30 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 7 | 23% |
| United States | 4 | 13% |
| Belgium | 2 | 7% |
| Japan | 2 | 7% |
| France | 1 | 3% |
| Mexico | 1 | 3% |
| Australia | 1 | 3% |
| Unknown | 12 | 40% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 22 | 73% |
| Scientists | 4 | 13% |
| Science communicators (journalists, bloggers, editors) | 3 | 10% |
| Practitioners (doctors, other healthcare professionals) | 1 | 3% |
Mendeley readers
The data shown below were compiled from readership statistics for 105 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | <1% |
| United States | 1 | <1% |
| Germany | 1 | <1% |
| Unknown | 102 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 22 | 21% |
| Student > Master | 15 | 14% |
| Student > Ph. D. Student | 14 | 13% |
| Student > Bachelor | 11 | 10% |
| Other | 8 | 8% |
| Other | 20 | 19% |
| Unknown | 15 | 14% |
| Readers by discipline | Count | As % |
|---|---|---|
| Agricultural and Biological Sciences | 27 | 26% |
| Medicine and Dentistry | 16 | 15% |
| Chemistry | 13 | 12% |
| Biochemistry, Genetics and Molecular Biology | 12 | 11% |
| Pharmacology, Toxicology and Pharmaceutical Science | 8 | 8% |
| Other | 10 | 10% |
| Unknown | 19 | 18% |
Attention Score in Context
This research output has an Altmetric Attention Score of 154. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 March 2022.
All research outputs
#265,817
of 25,397,764 outputs
Outputs from British Journal of Pharmacology
#52
of 7,948 outputs
Outputs of similar age
#2,946
of 272,734 outputs
Outputs of similar age from British Journal of Pharmacology
#3
of 80 outputs
Altmetric has tracked 25,397,764 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 7,948 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.0. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 272,734 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 80 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.